Leukemia Home > Campath for MS
The primary use for Campath® (alemtuzumab) is to treat leukemia, a type of cancer that affects the blood and bone marrow. At times, a drug may be given to treat a condition it is not approved to treat. This is called an off-label use. Currently accepted off-label uses for Campath include treating multiple sclerosis (MS) and rheumatoid arthritis, and preventing organ transplant rejection.
(Click Campath Uses for more information on this topic, including how this medicine works and whether children and older adults can use it.)